Upon recommendation by underwriters’ counsel, members of CRA’s accounting and advisory team assisted a US-based bio-technology company in advance of its IPO by advising on existing compliance procedures, tightening financial controls, and enhancing internal reporting, governance, and risk management functions. CRA team members recommended and implemented both qualitative and systems-based solutions designed to address regulatory requirements.
Over $2.9 billion recovered through settlements and judgments under the False Claims Act
The False Claims Act (FCA) remains one of the most powerful tools for combating fraudulent claims in government funding, with billions recovered annually. In...